Detalles de la búsqueda
1.
Endothelial Activation and Stress Index (EASIX) at Admission Predicts Fluid Overload in Recipients of Allogeneic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 26(5): 1013-1020, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32045652
2.
Allogeneic Transplantation after Myeloablative Rituximab/BEAM ± Bortezomib for Patients with Relapsed/Refractory Lymphoid Malignancies: 5-Year Follow-Up Results.
Biol Blood Marrow Transplant
; 25(7): 1347-1354, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30826465
3.
Prognostic significance of measurable residual disease in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation in second or later complete remission.
Am J Hematol
; 98(2): E35-E37, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36502492
4.
Feasibility of Lenalidomide Therapy for Persistent Chronic Lymphocytic Leukemia after Allogeneic Transplantation.
Biol Blood Marrow Transplant
; 23(8): 1405-1410, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28495642
5.
Impact of Fluid Overload as New Toxicity Category on Hematopoietic Stem Cell Transplantation Outcomes.
Biol Blood Marrow Transplant
; 23(12): 2166-2171, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28844946
6.
Clofarabine Plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: Long-Term Study Results.
Biol Blood Marrow Transplant
; 23(2): 285-292, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27816651
7.
Long-term follow-up of patients receiving allogeneic stem cell transplant for chronic lymphocytic leukaemia: mixed T-cell chimerism is associated with high relapse risk and inferior survival.
Br J Haematol
; 177(4): 567-577, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28295181
8.
Impact of TKIs post-allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive ALL.
Blood
; 136(15): 1786-1789, 2020 10 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32492706
9.
Outcomes of Haploidentical Stem Cell Transplantation for Lymphoma with Melphalan-Based Conditioning.
Biol Blood Marrow Transplant
; 22(3): 493-8, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26497906
10.
Gemcitabine, Fludarabine, and Melphalan for Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma.
Biol Blood Marrow Transplant
; 22(7): 1333-1337, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27064056
11.
Outcomes of adults with acute lymphoblastic leukemia relapsing after allogeneic hematopoietic stem cell transplantation.
Biol Blood Marrow Transplant
; 19(7): 1059-64, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23644077
12.
Clinical outcome of allogeneic stem cell transplantation in patients with B-cell lymphoid malignancies following treatment with targeted small molecule inhibitors.
Leuk Lymphoma
; 63(4): 885-893, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35225133
13.
Vorinostat Combined with Busulfan, Fludarabine, and Clofarabine Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Leukemia: Long-Term Study Outcomes.
Transplant Cell Ther
; 28(8): 501.e1-501.e7, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35618218
14.
Intravenous busulfan plus melphalan is a highly effective, well-tolerated preparative regimen for autologous stem cell transplantation in patients with advanced lymphoid malignancies.
Biol Blood Marrow Transplant
; 17(3): 412-20, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20674757
15.
Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma.
Blood
; 113(18): 4144-52, 2009 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-19168784
16.
Nine-Year Follow-up of Patients with Relapsed Follicular Lymphoma after Nonmyeloablative Allogeneic Stem Cell Transplant and Autologous Transplant.
Clin Cancer Res
; 27(21): 5847-5856, 2021 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34380640
17.
Management of Advanced and Relapsed/Refractory Extranodal Natural Killer T-Cell Lymphoma: An Analysis of Stem Cell Transplantation and Chemotherapy Outcomes.
Clin Lymphoma Myeloma Leuk
; 18(1): e41-e50, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29277360
18.
Hematopoietic cell transplantation can be safely performed after COVID-19.
Bone Marrow Transplant
; 58(12): 1410-1412, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37726490
19.
Stem cell transplantation outcomes in lymphoblastic lymphoma.
Leuk Lymphoma
; 58(2): 366-371, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27348707
20.
Outcomes in patients with CRLF2 overexpressed acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation.
Bone Marrow Transplant
; 56(7): 1746-1749, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33767403